Ligand validation:3EBZ

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3EBZ_IMD_B_301	99%	63%	0.059	0.99	0.35	1.03	-	-	0	0	100%	1
3EBZ_IMD_A_304	60%	66%	0.139	0.925	0.2	1.06	-	-	1	0	100%	0.5
3EBZ_IMD_B_303	56%	78%	0.194	0.968	0.24	0.64	-	-	1	0	100%	0.6
3EBZ_IMD_B_302	52%	70%	0.139	0.896	0.47	0.66	-	-	0	0	100%	1
3EBZ_IMD_B_305	51%	83%	0.202	0.958	0.07	0.69	-	-	0	0	100%	0.5
3EBZ_IMD_A_306	31%	80%	0.175	0.844	0.12	0.71	-	-	1	0	100%	0.5
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1
3NN1_IMD_B_243	99%	76%	0.049	0.986	0.35	0.59	-	-	0	0	100%	1
2ASN_IMD_X_202	99%	66%	0.051	0.987	0.4	0.87	-	-	1	0	100%	1
6LY4_IMD_A_502	99%	75%	0.059	0.989	0.23	0.73	-	-	0	0	100%	1
3ECG_IMD_B_301	99%	55%	0.057	0.986	0.56	1.16	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.